Yazed AlRuthia, Khaled Hani Aburisheh, Sondus Ata, Raghad Bin Salleeh, Shahad B. Alqudhibi, Raghad B. Alqudhibi, . . . Reem Al Khalifah. (2024). Cost consequence analysis of adding semaglutide to treatment regimen for patients with Type II diabetes in Saudi Arabia. Elsevier.
Chicago Style (17th ed.) CitationYazed AlRuthia, et al. Cost Consequence Analysis of Adding Semaglutide to Treatment Regimen for Patients with Type II Diabetes in Saudi Arabia. Elsevier, 2024.
MLA (9th ed.) CitationYazed AlRuthia, et al. Cost Consequence Analysis of Adding Semaglutide to Treatment Regimen for Patients with Type II Diabetes in Saudi Arabia. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.